9.38MMarket Cap-1.76P/E (TTM)
0.483High0.412Low61.68KVolume0.483Open0.475Pre Close27.03KTurnover0.66%Turnover RatioLossP/E (Static)21.26MShares13.10052wk High6.39P/B4.10MFloat Cap0.26052wk Low--Dividend TTM9.30MShs Float13.100Historical High--Div YieldTTM15.05%Amplitude0.260Historical Low0.438Avg Price1Lot Size
Klotho Neurosciences Stock Forum
Former Merck USA President Joins Klotho Neurosciences' Board of Directors
Tuesday, 3rd December at 11:00 am
NEW YORK, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Klotho Neurosciences, Inc. (NASDAQ: KLTO), a U.S.-based biotechnology company pioneering cell and gene therapies for neurodegenerative and age-related disorders, including ALS, Alzheimer's, and Parkinson's, today announced the appointment of Riad El-Dada, former US President of Merck, to its Board of Dire...
No comment yet